Big retail, U.S. Congress embrace EPCS in growing push to require E-prescribing for opioids

Listen
Text
  • Small
  • Medium
  • Large

The national opioid epidemic continues to run rampant, spurring leaders across private and public sectors to take action. Many are embracing electronic prescribing of controlled substances (EPCS) as a critical tool in response to the deepening crisis.

Editor's Note: This post originally appeared on Imprivata's website.

Leading private corporations like Walmart and McKesson have helped drive this momentum, each announcing plans involving EPCS. And both federal and state legislatures are matching this push, with a number of different EPCS mandates passed and bills filed recently.

Click here to read more about the effort to combat the opioid crisis.

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars